Seeking Alpha

GlaxoSmithKline (GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a...

GlaxoSmithKline (GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a share. HGSI shares +3%. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|